We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Labeling Requirements at Heart of Prandin Lawsuit
FDA’s Labeling Requirements at Heart of Prandin Lawsuit
April 9, 2010
A U.S. district court has dismissed a patent-infringement lawsuit filed by Novo Nordisk related to its diabetes drug Prandin and FDA labeling requirements.